First to File Bioequivalency

Frontage assisted a Sponsor that required accelerated timelines in order to be the first to file a generic anti-epilepsy drug. As a result, the study required a high degree of upfront planning and coordination.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Name

This field is for validation purposes and should be left unchanged.

First to File Bioequivalency

Resources to Consider

Cost Effective and Efficient Progression of Lead Drug Candidates to...

Recruiting Women for First-in-Human Trials: Tips for Success

Addressing the Increasing Needs of Data Integrity by Implementing the...

A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication...

A Hybrid Trial Approach by Combining 13C8-Lableded & Radiolabeled...

Genotoxic Potential of an Antiviral Pyrimidine Nucleoside Analogue,...

Optimization and standardization of RNA-seq operation to get...

DMPK Virtual Tour

Testing of Carryover & After MRD Benchtop Stability for...

Alignment on Laboratory Support for Clinical Trials

Frontage Hayward, CA Site Virtual Tour

Frontage 760 Site Virtual Tour